Literature DB >> 31814914

Circular RNA profile in coronary artery disease.

Ren-You Pan1, Chen-Hui Zhao2, Jin-Xia Yuan2, Yong-Jie Zhang3, Jian-Liang Jin3, Mu-Feng Gu3, Zhi-Yuan Mao3, Hai-Jian Sun3, Qiao-Wei Jia2, Ming-Yue Ji2, Jing Zhang2, Lian-Sheng Wang2, Wen-Zhu Ma2, Wen-Qi Ma4, Jian-Dong Ding4, En-Zhi Jia2.   

Abstract

Circular RNAs (circRNAs) are potential biomarkers and therapeutic targets of coronary artery disease due to their high stability, covalently closed structure. And implied roles in gene regulation. The aim of this study was to identify and characterize circRNAs from human coronary arteries. Epicardial coronary arteries were removed during the autopsy of an 81-year-old man who died from heart attack. The natural history and histological classification of atherosclerotic lesions in coronary artery segments were analyzed by hematoxylin and eosin staining, and their circRNA expression profiles were characterized by RNA sequencing. RNA sequencing identified 1259 annotated and 381 novel circRNAs. Combined with the results of histologic examination, intersection analysis identified 54 upregulated and 12 downregulated circRNAs, representing 4.0% of the total number. Coronary artery segments with or without severe atherosclerosis showed distinctly different circRNA profiles on the basis of hierarchical clustering. Our results suggest that these 66 circRNAs contribute to the pathology underlying coronary artery atherosclerosis and may serve as diagnostic or therapeutic targets in coronary artery disease. AJTR
Copyright © 2019.

Entities:  

Keywords:  Coronary artery; RNA sequencing; atherosclerosis; circular RNA; coronary artery disease

Year:  2019        PMID: 31814914      PMCID: PMC6895512     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  23 in total

Review 1.  Natural history and histological classification of atherosclerotic lesions: an update.

Authors:  H C Stary
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 2.  CircRNAs and cancer: Biomarkers and master regulators.

Authors:  Esther Arnaiz; Carla Sole; Lorea Manterola; Leire Iparraguirre; David Otaegui; Charles H Lawrie
Journal:  Semin Cancer Biol       Date:  2018-12-11       Impact factor: 15.707

3.  Translation of CircRNAs.

Authors:  Nagarjuna Reddy Pamudurti; Osnat Bartok; Marvin Jens; Reut Ashwal-Fluss; Christin Stottmeister; Larissa Ruhe; Mor Hanan; Emanuel Wyler; Daniel Perez-Hernandez; Evelyn Ramberger; Shlomo Shenzis; Moshe Samson; Gunnar Dittmar; Markus Landthaler; Marina Chekulaeva; Nikolaus Rajewsky; Sebastian Kadener
Journal:  Mol Cell       Date:  2017-03-23       Impact factor: 17.970

4.  Discriminating cirRNAs from other lncRNAs using a hierarchical extreme learning machine (H-ELM) algorithm with feature selection.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; ShaoPeng Wang; Tao Huang; Yu-Dong Cai
Journal:  Mol Genet Genomics       Date:  2017-09-14       Impact factor: 3.291

Review 5.  Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data.

Authors:  A P J J Bijnens; E Lutgens; T Ayoubi; J Kuiper; A J Horrevoets; M J A P Daemen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-30       Impact factor: 8.311

6.  The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva.

Authors:  Jae Hoon Bahn; Qing Zhang; Feng Li; Tak-Ming Chan; Xianzhi Lin; Yong Kim; David T W Wong; Xinshu Xiao
Journal:  Clin Chem       Date:  2014-11-06       Impact factor: 8.327

7.  Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown.

Authors:  Mihaela Pertea; Daehwan Kim; Geo M Pertea; Jeffrey T Leek; Steven L Salzberg
Journal:  Nat Protoc       Date:  2016-08-11       Impact factor: 13.491

8.  CIRI: an efficient and unbiased algorithm for de novo circular RNA identification.

Authors:  Yuan Gao; Jinfeng Wang; Fangqing Zhao
Journal:  Genome Biol       Date:  2015-01-13       Impact factor: 13.583

9.  Transcriptional Alterations by Ischaemic Postconditioning in a Pig Infarction Model: Impact on Microvascular Protection.

Authors:  Dominika Lukovic; Alfred Gugerell; Katrin Zlabinger; Johannes Winkler; Noemi Pavo; Tamás Baranyai; Zoltán Giricz; Zoltán V Varga; Martin Riesenhuber; Andreas Spannbauer; Denise Traxler; András Jakab; Rita Garamvölgyi; Örs Petnehazy; Dietmar Pils; Levente Tóth; Rainer Schulz; Péter Ferdinandy; Mariann Gyöngyösi
Journal:  Int J Mol Sci       Date:  2019-01-15       Impact factor: 5.923

10.  Mapping macrophage polarization over the myocardial infarction time continuum.

Authors:  Alan J Mouton; Kristine Y DeLeon-Pennell; Osvaldo J Rivera Gonzalez; Elizabeth R Flynn; Tom C Freeman; Jeffrey J Saucerman; Michael R Garrett; Yonggang Ma; Romain Harmancey; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2018-06-04       Impact factor: 17.165

View more
  15 in total

1.  Circ_ROBO2/miR-186-5p/TRIM14 axis regulates oxidized low-density lipoprotein-induced cardiac microvascular endothelial cell injury.

Authors:  Qinghu Ye; Changlin Ju; Zhou Ye; Jiaqiong Tong
Journal:  Regen Ther       Date:  2022-05-10       Impact factor: 3.651

2.  Circular RNA circ_0001445 alleviates the ox-LDL-induced endothelial injury in human primary aortic endothelial cells through regulating ABCG1 via acting as a sponge of miR-208b-5p.

Authors:  Zhihua Yang; Xing Liang; Lixia Yang
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-04-07

3.  LncRNA Landscape of Coronary Atherosclerosis Reveals Differentially Expressed LncRNAs in Proliferation and Migration of Coronary Artery Smooth Muscle Cells.

Authors:  Yaqing Zhou; Sheng Zhang; Wenfeng Ji; Xiongkang Gan; Lei Hua; Can Hou; Jiaxin Chen; Yanjun Wang; Shu He; Hanxiao Zhou; Enzhi Jia
Journal:  Front Cell Dev Biol       Date:  2021-05-18

Review 4.  A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease.

Authors:  Priscilla R Prestes; Michelle C Maier; Bradley A Woods; Fadi J Charchar
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

5.  Hsa_circ_0018818 knockdown suppresses tumorigenesis in non-small cell lung cancer by sponging miR-767-3p.

Authors:  Xiaohui Xu; Xiaoyun Zhou; Chao Gao; Yushang Cui
Journal:  Aging (Albany NY)       Date:  2020-05-01       Impact factor: 5.682

6.  Quantitative proteomics reveals the regulatory networks of circular RNA BTBD7_hsa_circ_0000563 in human coronary artery.

Authors:  Jia-Xin Chen; Lei Hua; Chen-Hui Zhao; Qiao-Wei Jia; Jing Zhang; Jin-Xia Yuan; Yong-Jie Zhang; Jian-Liang Jin; Mu-Feng Gu; Zhi-Yuan Mao; Hai-Jian Sun; Lian-Sheng Wang; Wen-Zhu Ma; En-Zhi Jia
Journal:  J Clin Lab Anal       Date:  2020-07-25       Impact factor: 2.352

7.  CircUSP36 knockdown alleviates oxidized low‑density lipoprotein‑induced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR‑20a‑5p/ROCK2 axis.

Authors:  Jun Miao; Bo Wang; Ran Shao; Yan Wang
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

8.  circRNA‑0006896‑miR1264‑DNMT1 axis plays an important role in carotid plaque destabilization by regulating the behavior of endothelial cells in atherosclerosis.

Authors:  Yan Wen; Yao Chun; Zhong Qing Lian; Zhang Wei Yong; Yang Mei Lan; Liao Huan; Chen Yi Xi; Li Shu Juan; Zhong Wen Qing; Cheng Jia; Zhang Huan Ji
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

9.  CircSLC8A1 and circNFIX can be used as auxiliary diagnostic markers for sudden cardiac death caused by acute ischemic heart disease.

Authors:  Meihui Tian; Jiajia Xue; Cuiyun Dai; Enzhu Jiang; Baoli Zhu; Hao Pang
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

10.  Association between circular RNA expression content and severity of coronary atherosclerosis in human coronary artery.

Authors:  Can Hou; Lingfeng Gu; Yi Guo; Yaqing Zhou; Lei Hua; Jiaxin Chen; Shu He; Sheng Zhang; Qiaowei Jia; Chenhui Zhao; Jing Zhang; Guangxu Xu; Enzhi Jia
Journal:  J Clin Lab Anal       Date:  2020-09-05       Impact factor: 3.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.